Literature DB >> 6982682

Mutation frequency of Haemophilus influenzae to rifampin resistance.

P M Mendelman, M C Roberts, A L Smith.   

Abstract

Twenty-two susceptible strains of Haemophilus influenzae were examined for mutation to rifampin resistance (minimal inhibitory concentration, greater than or equal to 10 micrograms/ml). All strains had detectable apparent mutation frequencies with a median minimal inhibitory concentration 2,000-fold greater than that of their wild-type parents. Of the type b strain mutants, 80% (8 of 10) expressed high-level resistance (minimal inhibitory concentration, 750 micrograms/ml) that was 75-fold greater than readily achievable serum concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6982682      PMCID: PMC183781          DOI: 10.1128/AAC.22.3.531

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Use of antiserum agar for detection of Haemophilus influenzae type b in the pharynx.

Authors:  R H Michaels; F E Stonebraker; J B Robbins
Journal:  Pediatr Res       Date:  1975-05       Impact factor: 3.756

2.  Use of the Minitek system for biotyping Haemophilus species.

Authors:  A E Back; T R Oberhofer
Journal:  J Clin Microbiol       Date:  1978-03       Impact factor: 5.948

3.  The type b capsulation locus of Haemophilus influenzae: map location and size.

Authors:  B W Catlin; J W Bendler; S H Goodgal
Journal:  J Gen Microbiol       Date:  1972-05

4.  Emergence of rifampin-resistant Haemophilus influenzae after prophylaxis.

Authors:  T V Murphy; G H McCracken; T C Zweighaft; E J Hansen
Journal:  J Pediatr       Date:  1981-09       Impact factor: 4.406

5.  Comparative virulence of Haemophilus influenzae with a type b or type d capsule.

Authors:  M Roberts; T L Stull; A L Smith
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

Review 6.  Spread of Haemophilus influenzae type b: recent epidemiologic and therapeutic considerations.

Authors:  D M Granoff; R S Daum
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

7.  In-vitro and in-vivo studies of resistance to rifampin in meningococci.

Authors:  T C Eickhoff
Journal:  J Infect Dis       Date:  1971-04       Impact factor: 5.226

8.  A taxonomic study of the genus Haemophilus, with the proposal of a new species.

Authors:  M Kilian
Journal:  J Gen Microbiol       Date:  1976-03

9.  Competence mutants. II. Physical and biological fate of donor transforming deoxyribonucleic acid.

Authors:  E H Postel; S H Goodgal
Journal:  J Bacteriol       Date:  1972-01       Impact factor: 3.490

10.  Pharmacokinetics of rifampin in infants and children: relevance to prophylaxis against Haemophilus influenzae type b disease.

Authors:  G H McCracken; C M Ginsburg; T C Zweighaft; J Clahsen
Journal:  Pediatrics       Date:  1980-07       Impact factor: 7.124

View more
  2 in total

Review 1.  Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy.

Authors:  R de Groot; G Dzoljic-Danilovic; B van Klingeren; W H Goessens; H J Neyens
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

2.  Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.

Authors:  R S Daum; M P Glode; D Ambrosino; N Halsey; D A Goldmann; F J Mather; R Russell; J Kamon; M Murray; J D Band
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.